Barr Tamoxifen Sales Benefit From Zeneca's Risk Reduction Campaign
Executive Summary
Barr's tamoxifen sales increased by more than one-third in the third quarter of fiscal 1999, Barr CEO Bruce Downey said during an April 21 conference call.
You may also be interested in...
Bayer Comparing Vardenafil To Viagra In Attempt To Gain Edge In ED Market
Bayer is conducting comparative trials of vardenafil and Pfizer's Viagra (sildenafil) in an attempt to establish the benefits of its investigative drug over other erectile dysfunction agents.
Bayer Comparing Vardenafil To Viagra In Attempt To Gain Edge In ED Market
Bayer is conducting comparative trials of vardenafil and Pfizer's Viagra (sildenafil) in an attempt to establish the benefits of its investigative drug over other erectile dysfunction agents.
Andrx/Aventis Settle With FTC: Agency Says Cardizem CD Generic Not Delayed
Aventis and Andrx' consent agreement with the Federal Trade Commission includes an acknowledgement by the agency that the patent litigation settlement between the two companies did not delay the advent of generic competition to Cardizem CD.